会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Antipruritic agent
    • 止痒剂
    • US20050009917A1
    • 2005-01-13
    • US10493693
    • 2003-08-07
    • Fumie SatoIwai AraiNorikazu TakanoTohru TanamiMakoto Yagi
    • Fumie SatoIwai AraiNorikazu TakanoTohru TanamiMakoto Yagi
    • A61K31/5575A61P17/00A61P17/02A61P17/04A61P27/02A61P37/08A61K31/557
    • A61K31/5575Y10S514/861Y10S514/887
    • A pharmaceutical preparation for preventing or treating pruritic symptoms which contains as an effective ingredient a prostaglandin derivative represented by formula [1] wherein X1 and X2 which are different from each other represent a hydrogen atom, a halogen atom or a hydroxyl group; Y is an ethylene group, a vinylene group or an ethynylene group; Z is the formula (CH2)kA(CH2)hB(CH2)q, (CH2)kA(CH2)rA′(CH2)t (CH2)kB(CH2)hB′(CH2)q or (CH2)k-1B′(CH2)q-1A′wherein k is an integer of 1 to 4, h is an integer of 0 to 4, q is an integer 1 to 4, r is an integer of 0 to 4, and t is an integer of 0 to 2; A and A′ which may be the same or different represent an ethylene group, a vinylene group or an ethynylene group; B and B′ which may be the same or different represent an oxygen atom or a group represented by the formula S(O)u wherein u is an integer of 0 to 2; W1 is a hydroxyl group, a C1-10 alkyloxy group, a C3-10 cycloalkyloxy group, an aryloxy group or an arylalkyloxy group; W2 is a C1-10 alkyl group, a C2-10 alkenyl group, a C2-10 alkynyl group, a C3-10 cycloalkyl group, a C1-5 alkyl group substituted by C3-10 cycloalkyl group(s), or a group represented by the formula wherein W4 is a C1-10 alkyl group, a C2-10 alkenyl group, a C2-10 alkynyl group or a C1-5 alkyl group substituted by C3-10 cycloalkyl group(s); v is an integer of 0 to 4; W3 is a hydrogen atom or a methyl group, or W3 when taken together with W2 and the adjacent carbon atom forms a C3-10 cycloalkyl group; m is 0 or 1, a pharmaceutically acceptable salt thereof or a hydrate thereof.
    • 用于预防或治疗瘙痒症状的药物制剂,其含有作为有效成分的由式[1]表示的前列腺素衍生物,其中X 1和X 2彼此不同,表示氢原子,卤素原子或 羟基; Y是亚乙基,亚乙烯基或亚乙炔基; Z是式(CH2)kA(CH2)hB(CH2)q,(CH2)kA(CH2)rA'(CH2)t(CH2)kB(CH2)hB'(CH2)q或(CH2) '(CH 2)q-1A'其中k为1〜4的整数,h为0〜4的整数,q为1〜4的整数,r为0〜4的整数,t为 0〜2; A和A'可以相同或不同,表示亚乙基,亚乙烯基或亚乙炔基; B和B'可以相同或不同,表示氧原子或由式S(O)u表示的基团,其中u为0-2的整数; W 1是羟基,C 1-10烷氧基,C 3-10环烷氧基,芳氧基或芳基烷氧基; W 2是C 1-10烷基,C 2-10烯基,C 2-10炔基,C 3-10环烷基,被C 3-10环烷基取代的C 1-5烷基, 或由下式表示的基团,其中W 4是C 1-10烷基,C 2-10烯基,C 2-10炔基或被C 3-10环烷基取代的C 1-5烷基, ; v为0〜4的整数; W 3为氢原子或甲基时,W 3与W 2一起形成,相邻碳原子形成C3-10环烷基; m为0或1,其药学上可接受的盐或其水合物。